Answer
Jinarc (tolvaptan) is indicated to slow cyst development and renal insufficiency in adults with ADPKD, CKD stages 1–4 at treatment initiation, and evidence of rapidly progressing disease.
Sources for this answer
- Jinarc 15mg TabletsOtsuka Pharmaceuticals (UK) Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 17Document updated
Sources checked